Thrombogenics N.V. | Cash Flow
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
26,401.00
51,115.00
37,932.00
60,348.00
22,615.00
38,779
Depreciation, Depletion & Amortization
7,664.00
8,130.00
7,989.00
7,678.00
3,830.00
3,627
Other Funds
1,907.00
133.00
928.00
26,425.00
824.00
253
Funds from Operations
35,972.00
43,118.00
30,871.00
26,245.00
27,269.00
34,899
Changes in Working Capital
8,885.00
2,519.00
3,428.00
6,078.00
963.00
3,915
Net Operating Cash Flow
27,087.00
45,637.00
27,443.00
20,167.00
26,306.00
30,984
Capital Expenditures
5,496.00
583.00
354.00
1,572.00
246.00
Sale of Fixed Assets & Businesses
24.00
27.00
2.00
31.00
323.00
Purchase/Sale of Investments
1,031.00
3,938.00
4,191.00
13,773.00
27,738.00
Net Investing Cash Flow
4,441.00
3,493.00
3,178.00
15,281.00
27,584.00
Net Financing Cash Flow
2,960.00
-
-
-
-
Net Change in Cash
25,172.00
41,347.00
29,882.00
35,090.00
2,076.00
Free Cash Flow
24,945.00
46,208.00
27,797.00
20,739.00
26,060.00
Other Sources
-
111.00
1,365.00
33.00
77.00
Change in Capital Stock
2,960.00
-
-
-
-
Exchange Rate Effect
434.00
797.00
739.00
358.00
798.00
About Thrombogenics
View Profile
